Brenda L. Plassman, Ph.D., of Duke University Medical Center, with
Kenneth M. Langa, M.D., Ph.D., and David R. Weir, Ph.D., of the
University of Michigan, Robert B. Wallace, Ph.D., of the University of
Iowa, and others, conducted the analysis as part of the Aging,
Demographics and Memory Study (ADAMS). ADAMS is a sub-study of the
larger Health and Retirement Study (HRS), the leading resource for
data on the combined health and economic circumstances of Americans
over age 50. ADAMS and the HRS are sponsored by the National Institute
on Aging (NIA), a component of NIH, under a cooperative agreement with
the University of Michigan.
The study highlights the nationwide reach of dementia, which affects
not only those with the disease, but their families and communities as
well. "As the population ages during the next few decades, the
prevalence of Alzheimer's disease will increase several-fold unless
effective interventions are discovered and implemented," said NIA
Director Richard J. Hodes, M.D. "These data underscore the urgency of
research in this area."
The study included 856 HRS participants age 71 and older from 42
states in 2001-2003. ADAMS interviewers from Duke University Medical
School conducted at-home evaluations to gather information about each
participant's cognitive and functional status and symptoms,
neuropsychiatric symptoms, current medications, medical history and
family history of memory problems. Prior neuroimaging and laboratory
results were also obtained.
A team of clinicians reviewed the evaluation information and made a
preliminary assessment of each person's cognitive status. A consensus
panel of other medical experts then used well-accepted diagnostic
criteria to determine if the participant had normal cognitive
function, cognitive impairment without dementia, or dementia. Such
criteria further were used to discern the type of dementia, including
AD or vascular dementia, the second most common cause of dementia in
older adults.
Based on the experts' classifications, Drs. Plassman and Langa and co-
authors estimated the national prevalence and total numbers of people
age 71 and older, by age group, with any dementia and with AD or
vascular dementia in 2002. According to their calculations, 13.9
percent of Americans age 71 and older have some type of dementia, 9.7
percent of Americans in that age group have AD, and 2.4 percent have
vascular dementia. AD accounted for about 70 percent of all dementia
cases among people 71 and older.
As in other studies, the ADAMS analysis showed that the prevalence of
dementia increases significantly with age. Five percent of people ages
71 to 79, 24.2 percent of people 80 to 89, and 37.4 percent of those
90 years or older were estimated to have some type of dementia. The
estimated rate of Alzheimer's also rose greatly with older age -- from
2.3 percent of people ages 71 to 79 to 18.1 percent of people 80 to 89
to 29.7 percent of those age 90 and older. The ADAMS investigators
found fewer years of education and the presence of at least one APOE
e4 allele, a genetic risk factor for AD, to be strong predictors of AD
and other dementias.
Richard Suzman, Ph.D., director of NIA's Behavioral and Social
Research Program, which jointly directs the HRS, said the ADAMS data
will prove particularly valuable not only in assessing the prevalence
of dementia, but also its impact. "ADAMS, with its link to the data
about the health, economic, and family resources of individuals in the
study, will help us to characterize more fully the burden of dementia
on individuals, caregivers and the nation's health care system," he
says.
The ADAMS report is the latest published study to estimate the
prevalence of dementia and AD among older Americans. "These
assessments have provided a range of estimates, based on differing
methodologies and approaches," explains Dallas Anderson, Ph.D.,
program director for population studies in NIA's Dementias of Aging
Branch. For example, some studies have included lower age ranges than
ADAMS or broader characterizations of dementia, or have sampled
participants in a specific community as a base for national
extrapolations. A study reported in 1998 (Brookmeyer et al., 1998)
combined incidence data from four community-based studies, estimating
that national Alzheimer's prevalence among individuals age 60 years or
older would rise from 2.3 million in 1997 to 8.6 million in 2047.
Widely cited estimates based on the prevalence of Alzheimer's disease
in a Chicago-based community (Hebert et al., 2003), and an earlier
comparable study using data from East Boston (Evans et al., 1990)
forecast the number of those age 65 or older with AD to be 5.1 million
in 2010.
Despite the varied approaches and findings, however, NIA experts point
out, the numbers of people with dementia, and Alzheimer's
specifically, will certainly increase until ways to delay the
progression or prevent the dementia are found. Advancing age is the
most common known risk factor for Alzheimer's disease.